Clinical Trial Update: Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of postoperative adjuvant chemotherapy for stage II colon cancer with high-risk factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Adjuvant Chemotherapy | Phase 3 | Status: UNKNOWN